Use of a liver-specific promoter reduces immune response to the transgene in adenoviral vectors.

Source:http://linkedlifedata.com/resource/pubmed/id/10446917

Hum. Gene Ther. 1999 Jul 20 10 11 1773-81

Download in:

View as

General Info

PMID
10446917